GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kamada KMDA · USD

Health Care · US listing · 🇺🇸 United States

Compare

7.71

+6.64%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Kamada

Its shares trade under the ticker KMDA. It has been listed since 1 August 2005. In the fiscal year to 31 December 2025, it reported revenue of $180.5m and net income of $20.2m. At that date it held total assets of $378.8m and shareholders' equity of $269.1m.

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
1 Aug 2005
Employees
393
Website
kamada.com ↗
Head office
2 HOLTZMAN ST., SCIENCE PARK, REHOVOT, L3, 7670402
Incorporated in
L3
Classification
Pharmaceutical Preparations
Filer status
Accelerated filer

Leadership

Pay as last reported

  • Ms. Lilach Asher TopilskyChairman of the Board, since 2020
  • Mr. Amir LondonChief Executive Officer
  • Mr. David TsurDeputy Chairman of the Board, since 2015ILS 2.9m
  • Mr. Chaime OrlevChief Financial Officer
  • Dr. Ruth WolfsonSenior Vice President - Scientific AffairsILS 619,000
  • Mr. Barak BashariVice President - Operations
  • Mr. Nir LivnehVice President, General Counsel, Company Secretary
  • Ms. Shani DotanVice President - Human Resources
  • Ms. Yael BrennerVice President - Quality
  • Ms. Orit PinchukVice President - Regulatory Affairs and Quality R&D
  • Dr. Eran SchenkerVice President - Medical Director
  • Dr. Michal SteinVice President and Medical Director for Immunology

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Kamada Ltd has several key strengths that contribute to its success in the market. These strengths include:

Weaknesses

  • Despite its strengths, Kamada Ltd also has some weaknesses that it needs to address in order to maintain its competitive position:

Opportunities

  • There are various opportunities available for Kamada Ltd to further expand its business and drive growth:

Threats

  • Kamada Ltd faces certain threats that could potentially impact its performance and market position:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.